BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26175568)

  • 1. Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy.
    Kim EK; Chattranukulchai P; Klem I
    Korean J Radiol; 2015; 16(4):683-95. PubMed ID: 26175568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.
    Gould J; Porter B; Claridge S; Chen Z; Sieniewicz BJ; Sidhu BS; Niederer S; Bishop MJ; Murgatroyd F; Ganeshan B; Carr-White G; Razavi R; Chiribiri A; Rinaldi CA
    Heart Rhythm; 2019 Aug; 16(8):1242-1250. PubMed ID: 30849532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CMR imaging in risk stratification for sudden cardiac death.
    Aljaroudi WA; Flamm SD; Saliba W; Wilkoff BL; Kwon D
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):392-406. PubMed ID: 23473115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
    Acosta J; Fernández-Armenta J; Borràs R; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Andreu D; Soto-Iglesias D; Evertz R; Matiello M; Alonso C; Villuendas R; de Caralt TM; Perea RJ; Ortiz JT; Bosch X; Serra L; Planes X; Greiser A; Ekinci O; Lasalvia L; Mont L; Berruezo A
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):561-572. PubMed ID: 28780194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy.
    Demirel F; Adiyaman A; Timmer JR; Dambrink JH; Kok M; Boeve WJ; Elvan A
    Int J Cardiol; 2014 Dec; 177(2):392-9. PubMed ID: 25440471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis.
    Scott PA; Rosengarten JA; Curzen NP; Morgan JM
    Eur J Heart Fail; 2013 Sep; 15(9):1019-27. PubMed ID: 23558217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure).
    Flett A; Cebula A; Nicholas Z; Adam R; Ewings S; Prasad S; Cleland JG; Eminton Z; Curzen N
    Am Heart J; 2023 Dec; 266():149-158. PubMed ID: 37777041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
    Chen Z; Sohal M; Voigt T; Sammut E; Tobon-Gomez C; Child N; Jackson T; Shetty A; Bostock J; Cooklin M; O'Neill M; Wright M; Murgatroyd F; Gill J; Carr-White G; Chiribiri A; Schaeffter T; Razavi R; Rinaldi CA
    Heart Rhythm; 2015 Apr; 12(4):792-801. PubMed ID: 25533585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Cardiac Magnetic Resonance to Arrhythmic Risk Stratification in Nonischemic Cardiomyopathy.
    Di Marco A; Claver E; Anguera I
    Card Electrophysiol Clin; 2023 Sep; 15(3):379-390. PubMed ID: 37558307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Clustered Ventricular Arrhythmia and Cycle Length With Scar Burden in Cardiomyopathy.
    Vakil RM; Marine JE; Kolandaivelu A; Dickfeld T; Weiss RG; Tomaselli GF; Chrispin J; Wu KC
    JACC Clin Electrophysiol; 2022 Aug; 8(8):957-966. PubMed ID: 35981800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The scar: the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias.
    Pandozi C; Mariani MV; Chimenti C; Maestrini V; Filomena D; Magnocavallo M; Straito M; Piro A; Russo M; Galeazzi M; Ficili S; Colivicchi F; Severino P; Mancone M; Fedele F; Lavalle C
    J Interv Card Electrophysiol; 2023 Jan; 66(1):27-38. PubMed ID: 35072829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
    Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy international registry: Design and rationale of the DERIVATE study.
    Guaricci AI; Masci PG; Lorenzoni V; Schwitter J; Pontone G
    Int J Cardiol; 2018 Jun; 261():223-227. PubMed ID: 29550015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.